The role of the epidermal growth factor receptor in breast cancer.
about
ZIP: a novel transcription repressor, represses EGFR oncogene and suppresses breast carcinogenesisPlant sterols as anticancer nutrients: evidence for their role in breast cancerHER2 testing: a review of detection methodologies and their clinical performanceGene expression meta-analysis identifies metastatic pathways and transcription factors in breast cancerEpidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomes3,3'-Diindolylmethane (DIM) inhibits the growth and invasion of drug-resistant human cancer cells expressing EGFR mutantsGenetic and expression analysis of HER-2 and EGFR genes in salivary duct carcinoma: empirical and therapeutic significance.The epidermal growth factor receptor family in breast cancer.The Rac Inhibitor EHop-016 Inhibits Mammary Tumor Growth and Metastasis in a Nude Mouse Model.Grape polyphenols inhibit Akt/mammalian target of rapamycin signaling and potentiate the effects of gefitinib in breast cancer.Breast Tumor Angiogenesis and Tumor-Associated Macrophages: Histopathologist's PerspectiveMicrobead arrays for the analysis of ErbB receptor tyrosine kinase activation and dimerization in breast cancer cellsEpidermal growth factor receptor and AKT1 gene copy numbers by multi-gene fluorescence in situ hybridization impact on prognosis in breast cancerActivated HER-receptors in predicting outcome of ER-positive breast cancer patients treated with adjuvant endocrine therapyProlactin drives estrogen receptor-alpha-dependent ductal expansion and synergizes with transforming growth factor-alpha to induce mammary tumors in males.Effects of ectopic HER-2/neu gene expression on the COX-2/PGE2/P450arom signaling pathway in endometrial carcinoma cells: HER-2/neu gene expression in endometrial carcinoma cellsDetermination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors.EGFR/HER2 in breast cancer: a biological approach for molecular diagnosis and therapy.A novel isoform of the B cell tyrosine kinase BTK protects breast cancer cells from apoptosis.The molecular genetics of breast cancer and targeted therapyMammographic breast density and breast cancer risk by menopausal status, postmenopausal hormone use and a family history of breast cancer.Clinical utility of the combination of lapatinib and letrozole in the management of hormone receptor-positive and HER2-positive advanced breast cancerHistone H3 phosphorylation, immediate-early gene expression, and the nucleosomal response: a historical perspective.Validation of an in vitro model of erbB2(+) cancer cell redirection.Photoacoustic Imaging in Oncology: Translational Preclinical and Early Clinical Experience.A kinase inhibitor screen identifies Mcl-1 and Aurora kinase A as novel treatment targets in antiestrogen-resistant breast cancer cells.Four genetic variants interact to confer susceptibility to atopic dermatitis in Chinese Han population.ZNF516 suppresses EGFR by targeting the CtBP/LSD1/CoREST complex to chromatin.Chromosome 7 aneusomy in metaplastic breast carcinomas with chondroid, squamous, and spindle-cell differentiation.EGFR and HER2-Akt-mTOR signaling pathways are activated in subgroups of salivary gland carcinomas.Nuclear EGFR in ductal invasive breast cancer: correlation with cyclin-D1 and prognosis.
P2860
Q24318720-ACB1D1D9-6711-407A-8BF6-0E30A0880FE2Q26861053-15F8893C-5E67-4A40-B500-3A0E77357B3FQ28280488-622EC8C3-67DF-4727-AC4C-0CA903DF022CQ33396559-BFFB8B54-2C05-4259-B46F-CE948418FF9DQ33691211-83D88942-40C3-49BA-81E7-80D11D2941C0Q33937876-379A4AF2-FF03-4BBD-B101-7891C0EE4AC7Q34125003-912B1B75-012C-4306-8838-1E3CDE02AE0AQ34363400-7F382875-F6E5-4996-AEA7-FE80294FE17AQ34478364-EBEED4C9-0CEC-441F-85E7-1CEE959EA472Q34855692-EC1F9114-B129-44AB-99DF-D759C4294A4CQ35055683-170B50E7-DC9E-4A0C-BE46-4AA66EA684A5Q35379924-6B49BBB1-875A-48C0-9C74-DD6943F3FFC5Q35674231-BB2EC6F3-2ED1-44C0-BD88-D7CFBCA132CEQ36223407-058F1EEE-1871-4C03-839A-16953AE361E8Q36357467-0FF365E3-DA1B-47D0-BDA4-8D205C0A926EQ36722388-248CDD04-5827-465E-9F67-A6F5FC586B5EQ37205574-A6DC58A7-325E-459A-B138-27002F197781Q37206247-1B153FC6-E825-4632-AF49-3FDCAE41C4D2Q37222219-AF0CD446-2E28-468C-99AB-FD85809D2C2BQ37290512-C016C13B-D019-41B6-80D8-2F7F7C4CE674Q37318732-A5B52B68-6B2B-45BB-852E-14FD253287A7Q37356307-7BD6D7B2-1E42-4EF7-8A66-EEAD98AE9EC5Q37976424-AC2BFDE0-579D-4AB1-A0CF-26E071E4948EQ38883916-D9E480CA-A4A7-4B30-9ABC-20DF43293E52Q38900907-0782536C-2C7A-4D63-BEF3-F1B473243187Q38943401-5E7A8544-17CF-4646-9D17-F8EA02D6F38FQ41357931-2DAF9ED1-B84C-49F1-AC22-68897B6FA632Q41686713-DF17EB36-22F1-4F12-823F-36A00AFF8393Q42453112-D9593EF4-3F1A-440A-B654-50D1F91D7B32Q54495025-CB29B6A4-1E3F-475E-B709-DBD2DFD78427Q54699349-9232E436-CE07-436A-B7DD-865935B5C4FB
P2860
The role of the epidermal growth factor receptor in breast cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The role of the epidermal growth factor receptor in breast cancer.
@ast
The role of the epidermal growth factor receptor in breast cancer.
@en
type
label
The role of the epidermal growth factor receptor in breast cancer.
@ast
The role of the epidermal growth factor receptor in breast cancer.
@en
prefLabel
The role of the epidermal growth factor receptor in breast cancer.
@ast
The role of the epidermal growth factor receptor in breast cancer.
@en
P2093
P1476
The role of the epidermal growth factor receptor in breast cancer.
@en
P2093
Mark E Hill
Samuel K Chan
William J Gullick
P2888
P356
10.1007/S10911-006-9008-2
P577
2006-01-01T00:00:00Z